Denali Therapeutics Inc. Quarterly Depreciation, Depletion and Amortization in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Denali Therapeutics Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2018 to Q1 2024.
  • Denali Therapeutics Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $2.16M, a 78.5% decline year-over-year.
  • Denali Therapeutics Inc. annual Depreciation, Depletion and Amortization for 2023 was $16.7M, a 61.1% increase from 2022.
  • Denali Therapeutics Inc. annual Depreciation, Depletion and Amortization for 2022 was $10.4M, a 20.8% increase from 2021.
  • Denali Therapeutics Inc. annual Depreciation, Depletion and Amortization for 2021 was $8.59M, a 0.73% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.16M -$7.89M -78.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $10M +$7.97M +383% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $2.08M -$29K -1.38% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q1 2021 $2.11M -$1K -0.05% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $2.11M -$294K -12.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $2.4M +$1.55M +181% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $854K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.